Medicines Marketed by Fusion Healthcare Pvt Ltd

About Fusion Healthcare Pvt. Ltd.

Fusion Healthcare Pvt. Ltd. is a prominent player in the pharmaceutical sector, specialising in human health activities. Established in 2007, this private limited company has its headquarters in Hyderabad, Telangana. With a strong nationwide presence, Fusion Healthcare has also expanded its reach to international markets, showcasing its commitment to global growth.

The company actively participates in major Indian and international conferences, further solidifying its position as a trusted and respected entity in the pharmaceutical industry. Driven by core values of integrity, respect for people, and transparency, Fusion Healthcare aims to become one of the most successful and trusted pharmaceutical companies worldwide.

Fusion Healthcare Pvt. Ltd. Products

Fusion Healthcare Pvt. Ltd. is dedicated to the research, manufacturing, and marketing of a wide range of pharmaceutical products, with a special focus on anti-infectives and cardiology and metabolic medications. The company's state-of-the-art facilities are compliant with stringent international standards, including WHO-GMP, EU-GMP, and USFDA, ensuring the production of high-quality injectable products. Additionally, their oral formulation facilities are WHO-GMP and FDA-Philippines approved, further demonstrating their commitment to quality and reliability.

The company's product portfolio encompasses critical care, cardio-diabetes, and general specialities, with a focus on injectable and oral formulations. Fusion Healthcare also produces Active Pharmaceutical Ingredients (API) for several key drugs, such as glimepiride, montelukast, rivaroxaban, and dapagliflozin, in their WHO-GMP-approved facilities. While specific popular products are not detailed, the company's strong presence in these therapeutic areas suggests that their offerings are well-received by healthcare professionals and consumers alike.